Marina Milea spent her summer in the BSG-MSRP-Bio program, working in the Jacks Lab studying how KRAS-mutant lung cancers develop resistance to targeted therapies. This interview dives into her research experience w/ mentor Carrie Rodriguez & what makes the program unique. buff.ly/kQKiw1S

MIT Future Fest is coming to campus Sept. 30–Oct. 4! The KI will be part of the festival - with Sangeeta Bhatia, Noubar Afeyan, Kiran Mazumdar-Shaw &Susan Hockfield, plus a Future Lab offering a look inside KI’s cancer research. Explore the full program & ticket information: buff.ly/imze45Q

Congrats to the 2026 Angelika Amon Young Scientist Award winners: Rubén López Sandoval of @bsse.ethz.ch and Karin Goldberg of @weizmann.ac.il! Goldberg will present her work "Beyond Protein Breakdown: New Insights into Proteasomal Degradation in Innate Immunity” on 10/29 at 2 p.m. at the KI.

Congratulations to Matt Vander Heiden on his election to the Board of Directors of the Association of American Cancer Institutes (AACI)! Matt will begin his three-year term at the 2026 AACI/CCAF Annual Meeting in Chicago this October. bit.ly/4x9bBQ2

Congrats to the 2026 Angelika Amon Young Scientist Award winners: Ruben Lopez Sandoval of @bsse.ethz.ch and Karin Goldberg of @weizmann.ac.il! Established in memory of MIT biologist Angelika Amon, this award celebrates early-career researchers' curiosity and love of discovery science.

Put your science in the spotlight! The 2026 KI Image Awards competition is accepting submissions from MIT students, faculty & staff until Oct. 9th. We’re seeking striking imagery that captures the impact of cancer research in cancer, life sciences, engineering & beyond. mit-ki.org/ki-image-awa...

Former Forest White lab postdoc Ryuhjin Ahn and colleagues introduce INSIGHT, a method to identify signaling networks in specific tumor cell types. They used it to find regulators of invasive glioblastoma at the tumor periphery. buff.ly/4Cnqxvw

New paper from my group at @mitkochinstitute.bsky.social, MIT IMES, and MIT Biology! I am thrilled to share that our paper describing scAmp, a new method for analyzing extrachromosomal DNA amplifications at single-cell resolution, has been published in @natcomms.nature.com. Thread below 👇

Team MATCHMAKERS is tackling one of the biggest challenges in cancer immunology: understanding how T cells recognize cancer cells. Meet the researchers in the Birnbaum Lab & learn how their work could help advance more personalized immunotherapies. Watch now: www.youtube.com/watch?v=h06h...

Explore the research behind Kimberly Bennett's 2025 KI Images award-winning image. The new study, from the Hammond & Straehla labs, introduces a perfusable organ-on-a-chip model for studying pediatric brain tumors and therapies. 📄 mit-ki.org/4xiPWoO 🖼️ mit-ki.org/4gD8Spz

Congrats to Michael Birnbaum on receiving a 2025–2026 Technology Impact Award from @cancerresearchinst.bsky.social. His project aims to develop technology that rapidly identifies tumor-reactive T-cell receptors to advance personalized cancer immunotherapies. buff.ly/eO1mQ6j

Congratulations to 2026 Science Olympiad Alumni Research (SOAR) Grant winner Harrison Ngue! Harrison’s research uses chemical tags to study RNA inside cells, with the goal of developing new insights that could help advance cancer therapies. www.soinc.org/usafoundation

MIT and Dana-Farber Cancer Insitute researchers: The Bridge Project is now accepting proposals for translational cancer research projects. This program supports interdisciplinary teams tackling unmet needs in cancer care. Proposals due by 10:00AM EDT Tues, Oct.13, 2026. ki.mit.edu/research/ben...

Congratulations to Douglas Lauffenburger on being named an MIT Institute Professor, the highest honor bestowed on MIT faculty! This well-deserved recognition honors Doug's extraordinary contributions to research, education, and leadership. news.mit.edu/2026/emery-b...

A single image can reveal the beauty, complexity & impact of scientific discovery. The 2026 KI Image Awards Competition is now accepting submissions from MIT students, faculty & staff. Submit your biomedical images by Oct. 9 to be featured in the annual KI Images exhibition! buff.ly/z6VjjVI

MIT and Dana-Farber Cancer Insitute researchers: The Bridge Project is now accepting proposals for translational cancer research projects. Proposals are due by 10:00AM EDT Tuesday, October 13, 2026. For more details: ki.mit.edu/research/ben...

The Galloway Lab has shown that the order and orientation of neighboring genes control their expression. In a study appearing in Science, researchers created tandem gene circuits (one gene after another) and divergent circuits (genes pointed away from each other). mit-ki.org/4akQamv

MIT researchers including Ed Boyden made photonic devices by laser-carving hydrogel, then shrinking it to the nanoscale. They'll adapt this to classify cells in microfluidics and detect rare circulating tumor cells in blood samples. buff.ly/6o9vUgM

That’s a wrap on this year’s KI Annual Symposium on Diet & Metabolism in Cancer! Thanks to our speakers, attendees, organizers, volunteers & especially our sponsors for making the day a success!

Last chance to register for #KIAS2026: Diet & Metabolism in Cancer, this Thurs, June 18! The Clinical session - Translational applications for diet in anticancer therapy - features Andrew Chan (MGH), Oliver Maddocks (Faeth Therapeutics), and Valter Longo (USC). Don't miss it: mit-ki.org/4tv7Br9

We’re excited to see you at #KIAS2026: Diet & Metabolism in Cancer, this Thursday, June 18! Session 3 - Diet and the immune system - features Alison Ringel (MIT) and Eran Elinav (Weizmann Institute). Don't miss it - register today: : www.eventbrite.com/e/diet-metab...

There's still time to register for #KIAS2026: Diet & Metabolism in Cancer, this Thursday, June 18! Session 2 - Diet-gut interactions in cancer - features Omer Yilmaz (MIT) and Wendy Garrett (Harvard/Dana-Farber). Don't miss it! buff.ly/oUD9uBe

Just days left to register for #KIAS2026: Diet & Metabolism in Cancer, this Thursday, June 18! Session 1, Influence of diet on health and cancer, features Walter Willett, Mandar Muzumdar, and Matt Vander Heiden. Secure your spot now: mit-ki.org/4tv7Br9

Daniel Anderson, Robert Langer, and former postdoc Omid Veiseh have launched Duracyte, bringing implantable “living drug factories” one step closer to the clinic. mit-ki.org/4x9vZS4

Don’t miss the 2026 Koch Institute Annual Symposium on 6/18! This day-long symposium features leading experts discussing how nutritional & metabolic factors shape cancer development & therapy& spark interdisciplinary discussion to advance cancer prevention & treatment. Register: mit-ki.org/4tv7Br9

How does chromatin move inside the nucleus? Researchers in the Hansen Lab identified two distinct movement patterns — rapid local motion and slower long-range motion — that may help shape interactions between genes and regulatory elements. buff.ly/32HBaaZ

How do nutrition & metabolism influence cancer? That’s one of the central questions at the 2026 Koch Institute Annual Symposium. On 6/18, leading experts will come together to explore this topic & highlight new insights that can advance cancer prevention & treatment. Register: mit-ki.org/4tv7Br9

Congratulations to Robert Langer — 2026 recipient of the Robert A. Welch Award in Chemistry! His groundbreaking work on controlled drug release and tissue engineering has shaped medicine worldwide. welch1.org/awards/welch-award-in-chemistry

Registration is open for the 2026 Koch Institute Symposium! On 6/18, experts will explore how nutritional & metabolic factors influence cancer development & therapy foster interdisciplinary discussions & highlight insights that can advance cancer prevention & treatment Register: mit-ki.org/4tv7Br9

Missed Inside INLEXZO on April 29? The recording is now live. Michael Cima and Karen Daniel, PhD ’09, take you inside INLEXZO™—a newly FDA-approved therapy for muscle-invasive bladder cancer—and the pretzel-shaped platform behind it. Watch the video: www.youtube.com/watch?v=fEt8...

Inside INLEXZO™: Pretzels, Platforms and Progress Against Bladder Cancer

Learn the origin story behind the development and recent FDA approval of INLEXZO™, a new treatment for muscle invasive bladder cancer, and the pretzel-shaped drug delivery platform behind it.…

youtube.com